Find More Contacts for Promentis Pharmaceuticals
Protected Content
Non-Management
1 email found
View contacts for Promentis Pharmaceuticals to access new leads and connect with decision-makers.
View All Contacts
  • Company Type For Profit
  • Contact Email contact@promentispharma.com
  • Phone Number (414)238-2992
Promentis Pharmaceuticals discovers, develops, and markets new drugs for the treatment of important human diseases, focusing initially on developing a new antipsychotic drug to treat schizophrenia. Promentis Pharmaceuticals was founded in 2006 and is based in Milwaukee, Wisconsin.

Lists Featuring This Company

Medical Companies With Less Than $1M in Revenue (Top 10K)
9,767 Number of Organizations • $20.5B Total Funding Amount • 4,346 Number of Investors
United States Biotechnology Companies (Top 10K)
9,982 Number of Organizations • $690B Total Funding Amount • 29,933 Number of Investors
Biotechnology Companies With Less Than $500M in Revenue (Top 10K)
9,989 Number of Organizations • $615.9B Total Funding Amount • 41,307 Number of Investors
Midwestern US Pharmaceutical Companies
1,399 Number of Organizations • $30B Total Funding Amount • 559 Number of Investors

Frequently Asked Questions

Where is Promentis Pharmaceuticals's headquarters? Promentis Pharmaceuticals is located in Milwaukee, Wisconsin, United States.Who invested in Promentis Pharmaceuticals? Promentis Pharmaceuticals has 8 investors including F-Prime Capital and Aisling Capital.How much funding has Promentis Pharmaceuticals raised to date? Promentis Pharmaceuticals has raised .When was the last funding round for Promentis Pharmaceuticals? Promentis Pharmaceuticals closed its last funding round on Dec 23, 2019 from a Venture - Series Unknown round.Who are Promentis Pharmaceuticals's competitors? Alternatives and possible competitors to Promentis Pharmaceuticals may include Acceleron PharmaPhaseBio Pharmaceuticals, and Apellis Pharmaceuticals.